Biocon Limited and its European partner, Zentiva, have reached a pivotal milestone. The companies have gained regulatory approval under the Decentralised Procedure (DCP) in the European Union (EU) for their complex formulation, Liraglutide. Biocon will handle the production and supply of Liraglutide, which Zentiva will distribute and market across 30 European countries. Understanding Liraglutide and …